Visualitza per autor "Makker, Vicky"
Ara mostrant els elements 1-3 d 3
-
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Makker, Vicky; González Martín , Antonio ; Meric-Bernstam, Funda; OAKNIN, ANA; OH, DO-YOUN; Banerjee, Susana (American Society of Clinical Oncology, 2024-01) -
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Taylor, Matthew H.; Aghajanian, Carol; Mier, James; Cohn, Allen L.; Makker, Vicky; OAKNIN, ANA (American Society of Clinical Oncology, 2020-09-10) -
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer
Voss, Martin H.; Gordon, Michael S.; Mita, Monica; Rini, Brian; Macarulla Mercadé, Teresa; Makker, Vicky (Springer Nature, 2020-11)